Amphastar Pharmaceuticals
AMPH
AMPH
168 hedge funds and large institutions have $678M invested in Amphastar Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 62 increasing their positions, 48 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.81% more ownership
Funds ownership: 58.15% → 60.96% (+2.8%)
Holders
168
Holding in Top 10
–
Calls
$291K
Puts
–
Top Buyers
| 1 | +$8.15M | |
| 2 | +$5.07M | |
| 3 | +$4.97M | |
| 4 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$4.9M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$2.48M |
Top Sellers
| 1 | -$5.67M | |
| 2 | -$2.88M | |
| 3 | -$1.88M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$1.47M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.27M |